Brief: Cleveland Biolabs - Named Christopher Zosh Interim Principal Executive Officer, Principal Financial Officer
Dec 18 (Reuters) - Cleveland Biolabs Inc CBLI.O :
* CLEVELAND BIOLABS - ON DEC 13, APPOINTED CHRISTOPHER ZOSH
AS
INTERIM PRINCIPAL EXECUTIVE OFFICER, PRINCIPAL FINANCIAL OFFICER
* CLEVELAND BIOLABS - CO'S BOARD CONTINUES ITS SEARCH FOR A
PERMANENT CEO
* CLEVELAND BIOLABS - ZOSH SUCCEEDS YAKOV KOGAN, WHOSE
RESIGNATION
AS CEO BECAME EFFECT ON DEC 13
Source text for Eikon: https://bit.ly/2ShaxKb
Further company coverage: CBLI.O
((Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc